level-one heading

Writers
Data Analysts
Consultants
Product Developers
Researchers
Why Kolabtree
Getting started is quick and easy. No upfront fees
It’s free to request a service and invite bids from experts
Discuss requirements with the expert in detail before accepting statement of work from Kolabtree
Collaborate with the expert directly to get your work done the right way
Fund project when you hire the expert, but approve the deliverables only once work is done
Want to hire this expert for a project? Request a quote for free.
Profile Details
Create Project
★★★★★
☆☆☆☆☆
USD 75 /hr
Hire Emil K.
Greece
USD 75 /hr

Clinical research specialist with 10 years+ experience of designing and implementing complex clinical trial projects

Profile Summary
Subject Matter Expertise
Services
Writing Clinical Trial Documentation
Research Scientific and Technical Research
Consulting Healthcare Consulting, Operations Consulting, Scientific and Technical Consulting
Work Experience

Project Lead - TB-PRACTECAL Clinical Tial

Médecins Sans Frontières‎

- Present

Clinical Trial Manager

Medecine Sans Frontiers

October 2016 - January 2021

Trials Network Manager

Blood Cancer UK

March 2014 - May 2016

Education

Master of Medical Science

University of Sheffield

September 2006 - June 2007

BSc

Sheffield Hallam University

September 2004 - May 2007

Certifications

  • ICH-Good clinical practice

    UK NIHR

    March 2016 - June 2024

Publications
JOURNAL ARTICLE
Nyang'wa BT, Berry C, Kazounis E, Motta I, Parpieva N, Tigay Z, Moodliar R, Dodd M, Solodovnikova V, Liverko I, et al.(2023). Short oral regimens for pulmonary rifampicin-resistant tuberculosis (TB-PRACTECAL): an open-label, randomised, controlled, phase 2B-3, multi-arm, multicentre, non-inferiority trial . The Lancet. Respiratory medicine.
Nyang'wa BT, Berry C, Kazounis E, Motta I, Parpieva N, Tigay Z, Solodovnikova V, Liverko I, Moodliar R, Dodd M, et al.(2022). A 24-Week, All-Oral Regimen for Rifampin-Resistant Tuberculosis . The New England journal of medicine.
Sweeney S, Berry C, Kazounis E, Motta I, Vassall A, Dodd M, Fielding K, Nyang'wa BT(2022). Cost-effectiveness of short, oral treatment regimens for rifampicin resistant tuberculosis . PLOS global public health.
Berry C, du Cros P, Fielding K, Gajewski S, Kazounis E, McHugh TD, Merle C, Motta I, Moore DAJ, Nyang'wa BT(2022). TB-PRACTECAL: study protocol for a randomised, controlled, open-label, phase II-III trial to evaluate the safety and efficacy of regimens containing bedaquiline and pretomanid for the treatment of adult patients with pulmonary multidrug-resistant tuberculosis . Trials.
Wharton-Smith A, Horter S, Douch E, Gray N, James N, Nyang'wa BT, Singh J, Nusratovna PN, Tigay Z, Kazounis E, et al.(2021). Optimising recruitment to a late-phase tuberculosis clinical trial: a qualitative study exploring patient and practitioner experiences in Uzbekistan . Trials.